News | April 13, 2022
BSV to set up vaccine manufacturing facility in Genome Valley
The total investment is in the region of Rs 200 crore
The total investment is in the region of Rs 200 crore
The investment of around €7 million significantly enhances the site’s flexibility and capacity in synthesizing modern, complex and even corrosive molecules
Both companies have been selected for stand-by production by German government
Gomez joins Moderna from Dentsply Sirona, where he served as Executive Vice President & Chief Financial Officer since August 2019
New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia
Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas
With close to 2,800 highly skilled employees, GITC is now one of the largest technology centres across the Life Sciences industry in the country
Essent continues to broaden its highly characterized, low passage primary cell catalog
The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.
The acquisition will strengthen Lupin’s India formulation business by adding a fast-growing portfolio of vitamins, minerals, supplements and neurological products
Subscribe To Our Newsletter & Stay Updated
